Stay updated on AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial

Sign up to get notified when there's something new on the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The AVP-786 study for agitation in Alzheimer's disease is terminated, with recruitment stopped and no participants currently being treated.
    Difference
    0.2%
    Check dated 2025-11-03T12:32:44.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T17:19:49.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.
    Difference
    0.3%
    Check dated 2025-09-28T10:03:58.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing v3.0.1. The Back to Top element has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:13:57.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T21:07:02.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The webpage has been updated to include new facility names and locations related to Alzheimer's disease and drug safety, while also removing some previous location terms and references. Notably, the page now emphasizes the availability of specific drugs and information for Alzheimer's caregivers.
    Difference
    6%
    Check dated 2025-08-30T15:41:59.000Z thumbnail image

Stay in the know with updates to AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page.